Tullis James L L - Net Worth and Insider Trading

Tullis James L L Net Worth

The estimated net worth of Tullis James L L is at least $26 Million dollars as of 2024-04-26. Tullis James L L is the Director of Alphatec Holdings Inc and owns about 1,741,821 shares of Alphatec Holdings Inc (ATEC) stock worth over $22 Million. Tullis James L L is the Director of Exagen Inc and owns about 1,542,988 shares of Exagen Inc (XGN) stock worth over $2 Million. Tullis James L L is also the Director of Crane Co and owns about 6,225 shares of Crane Co (CR) stock worth over $902,999. Besides these, Tullis James L L also holds electroCore Inc (ECOR) . Details can be seen in Tullis James L L's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tullis James L L has not made any transactions after 2023-09-11 and currently still holds the listed stock(s).

Transaction Summary of Tullis James L L

To

Tullis James L L Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tullis James L L owns 5 companies in total, including Exagen Inc (XGN) , Alphatec Holdings Inc (ATEC) , and Crane Co (CR) among others .

Click here to see the complete history of Tullis James L L’s form 4 insider trades.

Insider Ownership Summary of Tullis James L L

Ticker Comapny Transaction Date Type of Owner
XGN Exagen Inc 2021-08-05 director & 10 percent owner
ATEC Alphatec Holdings Inc 2023-09-11 director & 10 percent owner
CR Crane Co 2023-03-28 director
ECOR electroCore Inc 2020-04-14 director
CXT Crane NXT Co 2004-04-26 director

Tullis James L L Latest Holdings Summary

Tullis James L L currently owns a total of 4 stocks. Among these stocks, Tullis James L L owns 1,741,821 shares of Alphatec Holdings Inc (ATEC) as of September 11, 2023, with a value of $22 Million and a weighting of 85.03%. Tullis James L L owns 1,542,988 shares of Exagen Inc (XGN) as of August 5, 2021, with a value of $2 Million and a weighting of 8.5%. Tullis James L L also owns 6,225 shares of Crane Co (CR) as of November 24, 2021, with a value of $902,999 and a weighting of 3.53%. The other 1 stocks electroCore Inc (ECOR) have a combined weighting of 2.95% among all his current holdings.

Latest Holdings of Tullis James L L

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATEC Alphatec Holdings Inc 2023-09-11 1,741,821 12.50 21,764,053
XGN Exagen Inc 2021-08-05 1,542,988 1.41 2,175,613
CR Crane Co 2021-11-24 6,225 145.06 902,999
ECOR electroCore Inc 2020-04-14 133,454 5.65 754,015

Holding Weightings of Tullis James L L


Tullis James L L Form 4 Trading Tracker

According to the SEC Form 4 filings, Tullis James L L has made a total of 10 transactions in Alphatec Holdings Inc (ATEC) over the past 5 years, including 1 buys and 9 sells. The most-recent trade in Alphatec Holdings Inc is the sale of 105,000 shares on September 11, 2023, which brought Tullis James L L around $2 Million.

According to the SEC Form 4 filings, Tullis James L L has made a total of 14 transactions in Exagen Inc (XGN) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Exagen Inc is the sale of 6,800 shares on August 5, 2021, which brought Tullis James L L around $72,896.

According to the SEC Form 4 filings, Tullis James L L has made a total of 4 transactions in Crane Co (CR) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Crane Co is the sale of 2,000 shares on November 24, 2021, which brought Tullis James L L around $209,420.

More details on Tullis James L L's insider transactions can be found in the Insider Trading History of Tullis James L L table.

Insider Trading History of Tullis James L L

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tullis James L L Trading Performance

GuruFocus tracks the stock performance after each of Tullis James L L's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tullis James L L is 13.23%. GuruFocus also compares Tullis James L L's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tullis James L L within 3 months outperforms 5 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tullis James L L's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tullis James L L

Average Return

32.23%

Average return per transaction

Outperforming Transactions

55%

6 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.94 13.23 7.67 32.23 4.13 3.86
Relative Return to S&P 500(%) 15.38 12.1 9.07 22.88 -10.21 -5.98

Tullis James L L Ownership Network

Ownership Network List of Tullis James L L

No Data

Ownership Network Relation of Tullis James L L


Tullis James L L Owned Company Details

What does Exagen Inc do?

Who are the key executives at Exagen Inc?

Tullis James L L is the director & 10 percent owner of Exagen Inc. Other key executives at Exagen Inc include Chief Financial Officer Kamal Adawi , director & President and CEO John Aballi , and 10 percent owner Tullis Growth Fund Ii, L.p. .

Exagen Inc (XGN) Insider Trades Summary

Over the past 18 months, Tullis James L L made no insider transaction in Exagen Inc (XGN). Other recent insider transactions involving Exagen Inc (XGN) include a net sale of 25,343 shares made by Kamal Adawi , a net purchase of 56,181 shares made by John Aballi , and a net sale of 5,821 shares made by Mark Hazeltine .

In summary, during the past 3 months, insiders sold 19,522 shares of Exagen Inc (XGN) in total and bought 0 shares, with a net sale of 19,522 shares. During the past 18 months, 64,983 shares of Exagen Inc (XGN) were sold and 90,167 shares were bought by its insiders, resulting in a net purchase of 25,184 shares.

Exagen Inc (XGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Exagen Inc Insider Transactions

No Available Data

Tullis James L L Mailing Address

Above is the net worth, insider trading, and ownership report for Tullis James L L. You might contact Tullis James L L via mailing address: 100 First Stamford Place, Stamford Ct 06907.

Discussions on Tullis James L L

No discussions yet.